CYP19A1 and early-onset autosomal dominant Alzheimer disease: In this regard, aromatase would be an important neuroprotective molecule in humans, which is suggested by the existence of genetic variants of the enzyme that confer an increased risk of Alzheimer’s disease [101,102,103].